Tag Archive | "licensing"

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics

Tags: , , , , ,


The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.

Revised and updated 10th edition, includes:

  • Trends in co-promotion and co-marketing deals
  • Co-promotion and co-marketing agreement structure
  • Co-promotion and co-marketing contract documents
  • Top co-promotion deals by value
  • Top co-marketing deals by value
  • Most active co-promotion dealmakers
  • Most active co-marketing dealmakers

This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors.

Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2009 to end of May 2014.

The report provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace.

The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all co-promotion and co-marketing deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

 

Q2 Partnering and Licensing Pharma trends of 2014

Tags: , ,


July 2014

By Raveena Bhambra

Q2 was full of deals, coupled with the talk of potential deals, and overall it finished on a high with a large volume of agreements coming together in June. Read the full story

Industry trends in infectious vaccines dealmaking – 2009 to 2014

Tags: , , , ,


Industry trends suggest that infectious vaccines research and development is an increasingly active component of healthcare business development. The last decade has witnessed a significant number of infectious vaccines partnering and M&A activity Read the full story

Merck & Co

Tags: , , , ,


Merck & Co is a top pharmaceutical company based in Whitehouse Station, NJ, USA Read the full story

Licensing

Tags: ,


The granting of permission to use intellectual property rights, such as... Read the full story

Research, licensing and joint development agreement for imaging flow technology platform

Tags: , ,


EMD Millipore announced a clinical research, licensing and joint development agreement with Sysmex Corporation of Japan. Read the full story

Finding Biopharma Licensing and Collaboration Partners

Tags: , , , ,


The report takes the reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through to deal negotiation. Read the full story

Ablynx signs biotech deal for $2.3 billion with Merck

Tags: , , ,


Ablynx has entered into a second biotech deal for research collaboration and licensing agreement with a subsidiary of Merck & Co Read the full story

Big Pharma Deals and Alliances Review

Tags: , , , , ,


The Big pharma Deals and Alliances Review report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during the past year. Read the full story

Roche and Molecular Partners enter into a pharma licensing deal

Tags: , , , ,


Roche and Molecular Partners have entered into a research collaboration and licensing agreement for $1.169 billion. Read the full story